scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1445-5994.1974.TB03207.X |
P698 | PubMed publication ID | 4278910 |
P2093 | author name string | Glasgow GL | |
Willoughby EW | |||
Henley JW | |||
P2860 | cites work | Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor | Q41996129 |
Prevention or reversal of levodopa-induced cardiac arrhythmias by decarboxylase inhibitors | Q42230336 | ||
Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions | Q43495374 | ||
Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism | Q48775284 | ||
Levodopa in Parkinsonism: Potentiation of Central Effects with a Peripheral Inhibitor | Q51107835 | ||
Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa | Q55061662 | ||
P433 | issue | 4 | |
P921 | main subject | methyldopa | Q412621 |
(S)-(−)-carbidopa monohydrate | Q414225 | ||
Parkinson's disease | Q11085 | ||
P304 | page(s) | 373-378 | |
P577 | publication date | 1974-08-01 | |
P1433 | published in | Australian and New Zealand journal of medicine | Q27709236 |
P1476 | title | L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease. | |
P478 | volume | 4 |
Search more.